AstraZeneca working with Southeast Asia countries after delays from Thai plant

[Thaiger]

Following reports from several Southeast Asian countries regarding  delays in deliveries of the AstraZeneca Covid-19 vaccine from the Thailand manufacturing plant, the British-Swedish pharmaceutical company now says it is working with the governments to make sure the vaccine is supplied “as quickly as possible.” Malaysia, Taiwan and the Philippines have announced that they expect delays of the AstraZeneca vaccine from Thailand’s Siam Bioscience, a company wholly owned by a subsidiary of the Crown Property Bureau. The Siam Bioscience plant in Nonthaburi, just outside Bangkok, is set to be AstraZeneca’s Southeast Asia hub and manufacture 200 million doses. Over the past […]

The post AstraZeneca working with Southeast Asia countries after delays from Thai plant appeared first on Thaiger News.

Read the full story